Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07044505 · ClinicalTrials.gov registry record · NA

Molecular and Cellular Profiling of Uterine Lavage Collected During Gynecologic Surgery

A NA study of Gynecologic Cancer and Uterine Cancer, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT07044505 is a NA study of Gynecologic Cancer and Uterine Cancer that is actively recruiting participants, run by Stanford University. The registered enrollment target is 50 participants, below the 764-participant average among 55 other Gynecologic Cancer trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07044505, a NA study of Gynecologic Cancer and Uterine Cancer, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study is a designed as a to test the clinical and technical feasibility of using this novel uterine lavage collection catheter to collected UL samples from up to 50 individuals undergoing gynecologic surgery and to describe the cellular composition of these samples. In order to do this, it is a prospective consecutively-enrolled cohort of 50 participants, all of who will receive the intervention of uterine lavage collection.

Interventions

  • PROCEDURE Uterine Lavage

Study Locations (1)

California

  • Stanford University - Palo Alto

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-09-19
Est. Completion 2026-12
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT07044505

The ClinicalTrials.gov registry entry for NCT07044505 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 764-participant average among 55 other Gynecologic Cancer trials with a reported enrollment target (93% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Gynecologic Cancer appearing as the primary indexed condition, and to 1 intervention - of which Uterine Lavage is the first listed.

NCT07044505 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT07044505 about?

NCT07044505 is a clinical study titled "Molecular and Cellular Profiling of Uterine Lavage Collected During Gynecologic Surgery". This study is a designed as a to test the clinical and technical feasibility of using this novel uterine lavage collection catheter to collected UL samples from up to 50 individuals undergoing gynecologic surgery and to describe the cellular composition of these samples. In order to do this, it is a...

What is the current status of trial NCT07044505?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-09-19. Estimated completion is 2026-12.

What conditions does trial NCT07044505 study?

This clinical trial studies the following conditions: Gynecologic Cancer, Uterine Cancer, Gynecologic Disease, Gynecological Surgery.

What interventions are being tested in trial NCT07044505?

The interventions under investigation include: Uterine Lavage (PROCEDURE).

Who is sponsoring clinical trial NCT07044505?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07044505 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gynecologic Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.